Amgen Defends Neulasta Patent in Biosimilar Suit against Coherus By Sam | June 13, 2017 Amgen is suing Coherus Biosciences over its processes for manufacturing a biosimilar of Neulasta, saying it infringes patented methods for purifying proteins. Source: Generic Line Posted in Generic Line